Alex Lee, PhD, a bioinformatician in the Sweet-Cordero lab, recently received an R50 training grant from the NCI. In a Q&A, Lee talks about his childhood love of science, the wisdom of colleagues, and how he spends his free time. [read more] | |
|
A UCSF team led by Javid Moslehi, MD, in partnership with a team at Stanford, is working to reduce impacts of cardiotoxicities in cancer patients who receive kinase inhibitors. | |
|
Kole Roybal, PhD, and other researchers at UCSF and University of Washington, developed synthetic receptors on the surface of immune cells that could make cancer immunotherapies more targeted. | |
Open Enrollment Closes Nov 22 | |
|
Review your 2025 employee medical plan contribution, compare plans, and make sure your current choice still works for your health care needs and budget. View details. | |
Michael Cheng, MD was named the education and training liaison for the HDFCCC Molecular Oncology Program.
Katherine Van Loon, MD, MPH was named editor-in-chief of JCO Global Oncology.
Nola Hylton, PhD was elected to the National Academy of Medicine (NAM) for 2024.
Kevin Shannon, MD received the UCSF Lifetime Achievement in Mentoring Award.
Ana Velázquez Mañana, MD, MSc was selected to join the fourth cohort of the Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA).
Samuel Washington III, MD, MAS received a 2024 Young Investigator Award from the Prostate Cancer Foundation.
Pamela Ling, MD, MPH received a grant from the National Cancer Institute for a project, “Social media support groups for adolescent vaping cessation.”
In 2022, Scarlett Lin Gomez, MPH, PhD received a Breast Cancer Research Foundation award, funded by The Estée Lauder Companies Travel Retail division, to study early-onset breast cancer risk among Asian American ethnic groups. Watch a short video highlighting Dr. Gomez's research.
Congratulations to the recipients of HDFCCC Office of Education and Training Fall 2024 Travel Grants: Hassan Yousefi, Jie Jane Chen, Verima Pereira, Zhenmeiyu Li, and Mary Kate Howard.
| |
Ashworth A. Thirty years since the race to the BRCA1 gene. Nature. 2024 Oct;634(8036):1062-1063. doi: 10.1038/d41586-024-03358-6. PMID: 39478204.
Chou J, Robinson TM, Egusa EA, Lodha R, Zhang M, Badura M, Mikayelyan M, Delavan H, Swinderman J, Wilson C, Zhu J, Das R, Nguyen M, Loehr A, Golsorkhi T, Simmons A, Abida W, Chinnaiyan AM, Arkin MR, Small EJ, Quigley DA, Yang L, Kim M, Ashworth A, Feng FY. Synthetic Lethal Targeting of Cyclin Dependent Kinase-12-Deficient Prostate Cancer with PARP Inhibitors. Clin Cancer Res. 2024 Sep 25.
Guerra RA, Kaplan C, Borno H, Boscardin J, Alvarez EA, Lazar A, Chapman J, Swanson M, Ueda S, Chen LM. The role of race/ethnicity and age in clinical trial knowledge among patients with gynecologic malignancy. Gynecol Oncol. 2024 Nov;190:84-89.
| |
Cancer Community Connect Newsletter | |
View the November issue of Cancer Community Connect, a newsletter for cancer center trainees, staff, and faculty that focuses on opportunities in career development, mentorship, DEIA, and community engagement! | |
|
Nov 18: Computational Cancer Community (C3) Monthly Meeting
Peng He, PhD (UCSF) will present, "Developmental origins of cancer programs revealed by single-cell mapping of human fetal lungs."
Nov 20: Cancer Immunology and Immunotherapy Program Meeting
Save the date for a hybrid meeting of this cancer center research program.
Nov 21: CRISPR Cures for Cancer Symposium
Featuring a keynote by Jennifer Doudna, PhD, this one-day event will bring together investigators from the CRISPR Cures for Cancer network.
Nov 21: State of the University Address
Join Chancellor Sam Hawgood as he reflects on the major themes over past decade: growth, innovation, partnerships and disruption at UCSF.
Nov 22: Cancer Center Friday Seminar in Basic and Translational Research
Howard Chang, MD, PhD (Stanford University) will present, "Cancer genes beyond chromosomes."
Dec 4: Breast Oncology Program Seminar
Thea Tlsy, PhD (UCSF) will present, "Stromal Reprogramming to Prevent Multiple Cancers."
Dec 9: Oral, Head & Neck Cancer Research Group Seminar Series
Featuring Flora Momen-Heravi, DDS, PhD, MPH, MS, Professor of Periodontology and Division Chief of Periodontology at UCSF.
|
| | | |